Solicitation for Nominations for Members of the U.S. Preventive Services Task Force, 16367-16368 [07-1639]
Download as PDF
<![CDATA[
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices
The ALJ found that Ms. Uzelmeier’s
hearing request raised defenses that
either were immaterial to the charges of
misconduct in science or that the ALJ
had no authority to grant Ms.
Uzelmeier’s request for relief under Part
93.
Specifically, Ms. Uzelmeier
knowingly and intentionally;
• Fabricated and falsified data in her
research notebook primarily by multiple
instances of using data/results generated
from one experiment to represent data/
results purportedly obtained from one
or more entirely different experiments;
and
• Fabricated and falsified data in her
thesis entitled ‘‘Characterization of the
Molecular Mechanism(s) Underlying the
Interaction(s) between 2,3,7,8tetrachlorodibenzo-p-Dioxin Mediated
and Interferon Gamma Mediated Signal
Transduction,’’ including falsifying and
fabricating autoradiographic films,
computer image files scanned from
those films, numerical data reduced
from those computer files,
documentation of those results in her
black three-ring binder, and data in
associated multiple figures and
projection slides.
Ms. Uzlmeier’s research concerned
the interaction between the
environmental toxin, dioxin, and a
cytokine, interferon, on cellular
signaling in the immune system. The
approach was to exploit dioxin, or
‘‘TCDD’’ (2,3,7,8-tetrachlorodibenzo-pdioxin), as a probe that suppresses the
immune system to delineate a role for
the aryl hydrocarbon receptor protein
(AhR), which is a cytosolic receptor that
can be transported to the nucleus to also
act as a nuclear transcription factor. The
specific aim was to determine whether
the mechanism of action of a naturally
occurring regulatory factor, interferon-g
(IFN-g), to antagonize the
immunosuppressive actions of dioxin,
was through reduced AhR signaling.
Ms. Uzelmeier’s actions caused the
withdrawal of a manuscript that had
been submitted for publication, the
withdrawal of her mentor’s PHS grant
application, and her dismissal from
graduate school.
The following administrative actions
have been implemented for a period of
five (5) years, beginning on March 12,
2007:
(1) Ms. Uzelmeier has been debarred
from any contracting or subcontracting
with any agency of the United States
Government and from eligibility or
involvement in nonprocurement
programs of the United States
Government referred to as ‘‘covered
transactions’’ as defined in the
VerDate Aug<31>2005
17:57 Apr 03, 2007
Jkt 211001
debarment regulations at 2 CFR 180 and
376; and
(2) Ms. Uzelmeier is prohibited from
serving in any advisory capacity to PHS
including but not limited to service on
any PHS advisory committee, board,
and/or peer review committee, or as
consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. 07–1616 Filed 4–3–07; 8:45 am]
BILLING CODE 4160–17–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Solicitation for Nominations for
Members of the U.S. Preventive
Services Task Force
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Solicits nominations for new
members.
AGENCY:
SUMMARY: The Agency for Healthcare
Research and Quality (AHRQ) invites
nominations of individuals qualified to
serve as members of the U.S. Preventive
Services Task Force (the Task Force).
The Task Force, a standing,
independent panel of private-sector
experts in prevention and primary care,
is composed of members appointed to
serve for four-year terms with an option
for reappointment. New members are
selected each year to replace
(approximately) one fourth of the Task
Force members, i.e., those who are
completing their appointments.
Individuals nominated but not
appointed in previous years, as well as
those newly nominated, are considered
in the annual selection process.
Task Force members meet three times
a year for two days in the Washington,
DC area. Member duties include
reviewing and preparing comments (off
site) on systematic evidence reviews
prior to discussing and making
recommendations on preventive
services, drafting final recommendation
documents, and participating in
workgroups on specific topics or
methods. AHRQ particularly encourages
nominations of women, members of
minority populations, and persons with
disabilities. Interested individuals can
self nominate. Organizations and
individuals may nominate one or more
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
16367
persons qualified for membership on the
Task Force.
Qualification Requirements: The
mission of the Task Force is to produce
evidence-based recommendations on
the appropriate screening, counseling,
and provision of preventive medication
for asymptomatic patients seen in the
primary care setting. Therefore, in order
to qualify for the Task Force, an
applicant or nominee MUST
demonstrate the following:
1. Knowledge and experience in the
critical evaluation of research published
in peer reviewed literature and in the
methods of evidence review;
2. Understanding and experience in
the application of synthesized evidence
to clinical decision-making and/or
policy;
3. Expertise in disease prevention and
health promotion;
4. Ability to work collaboratively with
peers; and,
5. Clinical expertise in the primary
health care of children and/or adults,
and/or expertise in counseling and
behavioral interventions for primary
care patients. Some Task Force members
without primary health care clinical
experience may be selected based on
their expertise in methodological issues
such as medical decision making,
clinical epidemiology, behavioral
medicine, and health economics.
Strongest consideration will be given
to individuals who are recognized
nationally or intentionally for scientific
leadership within their field of
expertise. Applicants must have no
substantial conflicts of interest that
would impair the scientific integrity of
the work of the Task Force including
financial, intellectual, or other conflicts.
DATES: All nominations submitted in
writing or electronically, and received
by Thursday, May 31, 2007, will be
considered for appointment to the Task
Force.
Nominated individuals will be
selected for the Task Force on the basis
of their qualifications (in particular,
those that address the required
qualifications, outlined above) and the
current expertise needs of the Task
Force. It is anticipated that 4
individuals will be invited to serve on
the Task Force beginning in January,
2008. AHRQ will retain and consider for
future vacancies the nominations of
those not selected during this cycle.
ADDRESSES: Submit your responses
either in writing or electronically to:
Gloria Washington, ATTN: USPSTF
Nominations, Center for Primary Care,
Prevention, and Clinical Partnerships,
Agency for Healthcare Research and
Quality, 540 Gaither Road, Rockville,
E:\FR\FM\04APN1.SGM
04APN1
16368
Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices
Maryland 20850,
Gloria.Washington@ahrq.hhs.gov.
Nomination Submissions
Nominations may be submitted in
writing or electronically, but must
include (1) the applicant’s current
curriculum vitae and contact
information, (2) a letter explaining how
this individual meets the qualification
requirements and how he/she would
contribute to the Task Force. The letter
should also attest to the nominee’s
willingness to serve as a member of the
Task Force.
AHRQ will later ask persons under
serious consideration for membership to
provide detailed information that will
permit evaluation of possible significant
conflicts of interest. Such information
will concern matters such as financial
holdings, consultancies, and research
grants or contracts.
Nomination Selection
Nominations for the Task Force will
be selected on the basis of qualifications
as outlined above (see Qualification
Requirements) and the current expertise
needs of the Task Force.
Arrangement for Public Inspection
Nominations and applications are
kept on file at the Center for Primary
Care, Prevention and Clinical
Partnerships, and are available for
review during business hours. AHRQ
does not reply to individual responses,
but considers all nominations in
selecting members. Information
regarded as private and personal, such
as a nominee’s social security number,
home and internet addresses, home
telephone and fax numbers, or names of
family members will not be disclosed to
the public. This is in accord with
agency confidentiality policies and
Department regulations (45 CFR 5.67).
FOR FURTHER INFORMATION CONTACT:
Gloria Washington at
Gloria.Washington@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
jlentini on PROD1PC65 with NOTICES
Background
Under Title IX of the Public Health
Service Act, AHRQ is charged with
enhancing the quality, appropriateness,
and effectiveness of health care services
and access to such services. AHRQ
accomplishes these goals through
scientific research and promotion of
improvements in clinical practice,
including prevention of diseases and
other health conditions, and
improvements in the organization,
financing, and delivery of health care
services (42 U.S.C. 299–299c–7 as
amended by the Healthcare Research
VerDate Aug<31>2005
17:57 Apr 03, 2007
Jkt 211001
and Quality Act of 1999, codified in
scattered sections of 42 U.S.C.
The Task Force is an independent
expert panel, first established in 1984
under the auspices of the U.S. Public
Health Service. Currently, the USPSTF,
under AHRQ’s authorizing legislation
(see in particular, 42 U.S.C. 299b–4(a),
is convened at the call of the Director of
AHRQ. The Task Force is charged with
rigorously evaluating the effectiveness,
cost-effectiveness and appropriateness
of clinical preventive services and
formulating or updating
recommendations for primary care
clinicians regarding the appropriate
provision of preventive services. The
USPSTF transitioned to a standing Task
Force in 2001. Current Task Force
recommendations and associated
evidence reviews are available on the
Internet (https://
www.preventiveservices.ahrq.gov).
Dated: March 27, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–1639 Filed 4–3–07; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–06BD]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Joan Karr, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Economic Analysis of the National
Breast and Cervical Cancer Early
Detection Program—New National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC administers the National Breast
and Cervical Cancer Early Detection
Program (NBCCEDP) that provides
critical breast and cervical cancer
screening services to underserved
women in the United States, the District
of Columbia, 4 U.S. territories, and 13
American Indian/Alaska Native
organizations. The program provides
breast and cervical cancer screening for
eligible women who participate in the
program as well as diagnostic
procedures for women who have
abnormal findings. For the past decade,
the NBCCEDP has provided over 5
million breast and cervical cancer
screening and diagnostic exams to
almost 2.1 million low-income women.
Women diagnosed with cancer through
the program are eligible for Medicaid
coverage through the Breast and
Cervical Cancer Prevention and
Treatment Act passed by Congress in
2000.
The NBCCEDP is the largest organized
cancer screening program in the United
States but to date there has been no
systematic analysis of the economic
costs incurred by the program. CDC is
proposing to collect one year (period
covering 07/01/2005–06/30/2006) of
cost data from all the 68 NBCCEDP
grantees to assess the cost and costeffectiveness of the program. The
information required to perform an
activity-based cost analysis includes:
staff and consultant salaries, screening
costs, contracts and material costs,
provider payments, in-kind
contributions, administrative costs,
allocation of funds and staff time
devoted to specific program activities.
CDC has developed and tested a draft
questionnaire with 9 NBCCEDP grantees
to assess the ability of the grantees to
provide the cost data elements
requested, identify the cost information
required, and to complete the
questionnaire within the allocated
timeframe. The grantees were able to
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 72, Number 64 (Wednesday, April 4, 2007)]
[Notices]
[Pages 16367-16368]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1639]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Solicitation for Nominations for Members of the U.S. Preventive
Services Task Force
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Solicits nominations for new members.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) invites
nominations of individuals qualified to serve as members of the U.S.
Preventive Services Task Force (the Task Force).
The Task Force, a standing, independent panel of private-sector
experts in prevention and primary care, is composed of members
appointed to serve for four-year terms with an option for
reappointment. New members are selected each year to replace
(approximately) one fourth of the Task Force members, i.e., those who
are completing their appointments. Individuals nominated but not
appointed in previous years, as well as those newly nominated, are
considered in the annual selection process.
Task Force members meet three times a year for two days in the
Washington, DC area. Member duties include reviewing and preparing
comments (off site) on systematic evidence reviews prior to discussing
and making recommendations on preventive services, drafting final
recommendation documents, and participating in workgroups on specific
topics or methods. AHRQ particularly encourages nominations of women,
members of minority populations, and persons with disabilities.
Interested individuals can self nominate. Organizations and individuals
may nominate one or more persons qualified for membership on the Task
Force.
Qualification Requirements: The mission of the Task Force is to
produce evidence-based recommendations on the appropriate screening,
counseling, and provision of preventive medication for asymptomatic
patients seen in the primary care setting. Therefore, in order to
qualify for the Task Force, an applicant or nominee MUST demonstrate
the following:
1. Knowledge and experience in the critical evaluation of research
published in peer reviewed literature and in the methods of evidence
review;
2. Understanding and experience in the application of synthesized
evidence to clinical decision-making and/or policy;
3. Expertise in disease prevention and health promotion;
4. Ability to work collaboratively with peers; and,
5. Clinical expertise in the primary health care of children and/or
adults, and/or expertise in counseling and behavioral interventions for
primary care patients. Some Task Force members without primary health
care clinical experience may be selected based on their expertise in
methodological issues such as medical decision making, clinical
epidemiology, behavioral medicine, and health economics.
Strongest consideration will be given to individuals who are
recognized nationally or intentionally for scientific leadership within
their field of expertise. Applicants must have no substantial conflicts
of interest that would impair the scientific integrity of the work of
the Task Force including financial, intellectual, or other conflicts.
DATES: All nominations submitted in writing or electronically, and
received by Thursday, May 31, 2007, will be considered for appointment
to the Task Force.
Nominated individuals will be selected for the Task Force on the
basis of their qualifications (in particular, those that address the
required qualifications, outlined above) and the current expertise
needs of the Task Force. It is anticipated that 4 individuals will be
invited to serve on the Task Force beginning in January, 2008. AHRQ
will retain and consider for future vacancies the nominations of those
not selected during this cycle.
ADDRESSES: Submit your responses either in writing or electronically
to: Gloria Washington, ATTN: USPSTF Nominations, Center for Primary
Care, Prevention, and Clinical Partnerships, Agency for Healthcare
Research and Quality, 540 Gaither Road, Rockville,
[[Page 16368]]
Maryland 20850, Gloria.Washington@ahrq.hhs.gov.
Nomination Submissions
Nominations may be submitted in writing or electronically, but must
include (1) the applicant's current curriculum vitae and contact
information, (2) a letter explaining how this individual meets the
qualification requirements and how he/she would contribute to the Task
Force. The letter should also attest to the nominee's willingness to
serve as a member of the Task Force.
AHRQ will later ask persons under serious consideration for
membership to provide detailed information that will permit evaluation
of possible significant conflicts of interest. Such information will
concern matters such as financial holdings, consultancies, and research
grants or contracts.
Nomination Selection
Nominations for the Task Force will be selected on the basis of
qualifications as outlined above (see Qualification Requirements) and
the current expertise needs of the Task Force.
Arrangement for Public Inspection
Nominations and applications are kept on file at the Center for
Primary Care, Prevention and Clinical Partnerships, and are available
for review during business hours. AHRQ does not reply to individual
responses, but considers all nominations in selecting members.
Information regarded as private and personal, such as a nominee's
social security number, home and internet addresses, home telephone and
fax numbers, or names of family members will not be disclosed to the
public. This is in accord with agency confidentiality policies and
Department regulations (45 CFR 5.67).
FOR FURTHER INFORMATION CONTACT: Gloria Washington at
Gloria.Washington@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
Under Title IX of the Public Health Service Act, AHRQ is charged
with enhancing the quality, appropriateness, and effectiveness of
health care services and access to such services. AHRQ accomplishes
these goals through scientific research and promotion of improvements
in clinical practice, including prevention of diseases and other health
conditions, and improvements in the organization, financing, and
delivery of health care services (42 U.S.C. 299-299c-7 as amended by
the Healthcare Research and Quality Act of 1999, codified in scattered
sections of 42 U.S.C.
The Task Force is an independent expert panel, first established in
1984 under the auspices of the U.S. Public Health Service. Currently,
the USPSTF, under AHRQ's authorizing legislation (see in particular, 42
U.S.C. 299b-4(a), is convened at the call of the Director of AHRQ. The
Task Force is charged with rigorously evaluating the effectiveness,
cost-effectiveness and appropriateness of clinical preventive services
and formulating or updating recommendations for primary care clinicians
regarding the appropriate provision of preventive services. The USPSTF
transitioned to a standing Task Force in 2001. Current Task Force
recommendations and associated evidence reviews are available on the
Internet (https://www.preventiveservices.ahrq.gov).
Dated: March 27, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07-1639 Filed 4-3-07; 8:45 am]
BILLING CODE 4160-90-M
